Evolution of fit-for-purpose biomarker assay validations
What is it about?
A perspective paper about the current understanding of LBA biomarker assay validations. It provides a quick look at where the industry stands today by highlighting all of the relevant white papers and publications and summarizing where to start for your assay validation strategy and the best way to implement that into your work.
Why is it important?
Helps summarize the current industry thinking and provides insight into the best path forward for biomarker assay validations.
The following have contributed to this page: Robert Neely
In partnership with: